Trial Profile
The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal in Outpatient Surgeries - An Evaluation of Clinical and Associated Health Care Cost
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Aug 2021
Price :
$35
*
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 03 Aug 2021 Status changed from active, no longer recruiting to completed.
- 28 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Jun 2019 Planned End Date changed from 1 May 2019 to 15 Dec 2019.